These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15579042)

  • 1. Manganese enhanced magnetic resonance imaging.
    Lee JH; Koretsky AP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):529-37. PubMed ID: 15579042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-enhanced magnetic resonance imaging (MEMRI).
    Koretsky AP; Silva AC
    NMR Biomed; 2004 Dec; 17(8):527-31. PubMed ID: 15617051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer-based nanosized MRI contrast agents.
    Kobayashi H; Brechbiel MW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):539-49. PubMed ID: 15579043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated MR contrast agents.
    Lowe MP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):519-28. PubMed ID: 15579041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
    Lanza GM; Winter P; Caruthers S; Schmeider A; Crowder K; Morawski A; Zhang H; Scott MJ; Wickline SA
    Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.
    Aime S; Barge A; Cabella C; Crich SG; Gianolio E
    Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ.
    Ho C; Hitchens TK
    Curr Pharm Biotechnol; 2004 Dec; 5(6):551-66. PubMed ID: 15579044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring dynamic alterations in calcium homeostasis by T1-mapping manganese-enhanced MRI (MEMRI) in the early stage of small intestinal ischemia-reperfusion injury.
    Zhao DW; Zhang LT; Cheng HY; Zhang YL; Min JY; Xiao HL; Wang Y
    NMR Biomed; 2015 Aug; 28(8):958-66. PubMed ID: 26086648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring cell therapy using iron oxide MR contrast agents.
    Bulte JW; Kraitchman DL
    Curr Pharm Biotechnol; 2004 Dec; 5(6):567-84. PubMed ID: 15579045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain.
    Brunnquell CL; Hernandez R; Graves SA; Smit-Oistad I; Nickles RJ; Cai W; Meyerand ME; Suzuki M
    Contrast Media Mol Imaging; 2016 Sep; 11(5):371-380. PubMed ID: 27396476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirectly probing Ca(2+) handling alterations following myocardial infarction in a murine model using T(1)-mapping manganese-enhanced magnetic resonance imaging.
    Waghorn B; Schumacher A; Liu J; Jacobs S; Baba A; Matsuda T; Yanasak N; Hu TC
    Magn Reson Med; 2011 Jan; 65(1):239-49. PubMed ID: 20872864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection.
    Hou W; Toh TB; Abdullah LN; Yvonne TWZ; Lee KJ; Guenther I; Chow EK
    Nanomedicine; 2017 Apr; 13(3):783-793. PubMed ID: 28003120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects.
    Jørgensen JT; Rief M; Brismar TB; Wagner M; Albiin N
    Acta Radiol; 2012 Sep; 53(7):707-13. PubMed ID: 22821959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
    Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D
    Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering an effective Mn-binding MRI reporter protein by subcellular targeting.
    Bartelle BB; Mana MD; Suero-Abreu GA; Rodriguez JJ; Turnbull DH
    Magn Reson Med; 2015 Dec; 74(6):1750-7. PubMed ID: 25522343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI).
    Pautler RG
    NMR Biomed; 2004 Dec; 17(8):595-601. PubMed ID: 15761948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in metal-based probes for MR molecular imaging applications.
    Terreno E; Dastrù W; Delli Castelli D; Gianolio E; Geninatti Crich S; Longo D; Aime S
    Curr Med Chem; 2010; 17(31):3684-700. PubMed ID: 20846110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of cell surface receptors using targeted contrast agents.
    Artemov D; Bhujwalla ZM; Bulte JW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):485-94. PubMed ID: 15579038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
    McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
    Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations.
    Silva AC; Lee JH; Aoki I; Koretsky AP
    NMR Biomed; 2004 Dec; 17(8):532-43. PubMed ID: 15617052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.